FINWIRES · TerminalLIVE
FINWIRES

Tokyo Stock Exchange Issues Supervisory Designations for Three Firms Over Delisting Concerns

By

The Tokyo Stock Exchange has issued distinct supervisory designations for three companies due to compliance concerns, according to statements on the stock market operator's official website.

nms Holdings (TYO:2162) was placed under Securities Under Supervision (Confirmation) starting May 29 after approving a takeover bid by World Holdings that could lead to delisting via a cash-out or share consolidation that would leave minority holders with less than one share.

Bewith (TYO:9216), listed on the Prime Market, received the same designation from June 1, because it was deemed unlikely to meet continued listing criteria within the prescribed improvement period.

Meanwhile, Medical Net (TYO:3645), trading on the Growth Market, was designated as Securities Under Supervision (Examination) from June 1.

This examination status similarly reflects the company's inability to satisfy continued listing requirements within the improvement period, but it is specifically tied to a pending review regarding a potential transfer of market segment.

All three designations remain in effect until the TSE makes a final determination on whether delisting criteria have been met.

These actions highlight the exchange's ongoing oversight of listed companies' compliance with continued listing standards.

Related Articles

Asia

Genrix Grants CQ Pharmaceutical Distribution Rights for Myeloma Drug in China, Hong Kong, Macau, Taiwan

Chongqing Genrix Biopharmaceutical (SHA:688443) granted C.Q. Pharmaceutical (SHE:000950) subsidiary Yaoyou Pharmaceutical exclusive development and distribution rights for the GR1803 drug across China and Hong Kong, Macau, and Taiwan.The agreement covers development such as clinical trials, research, and manufacturing, as well as sales, the filing said.The GR1803 velitumimumab drug is indicated for multiple myeloma, a rare form of blood cancer.Yaoyou will pay Genrix up to 600 million yuan in initial payment, listing milestone, and technology transfer milestone payments.Genrix will also be eligible to receive sales royalties of up to a minimum percentage of two digits.

SHA:688443SHE:000950
Asia

Xuan Wu Cloud's CFO Steps Down

Xuan Wu Cloud Technology's (HKG:2392) Chief Financial Officer Ge Ping resigned to devote more time to personal affairs effective May 31, according to a Friday Hong Kong bourse filing.

HKG:2392
Asia

Update: Xi'an Eswin Materials Technology to Invest Up to 40 Million Yuan in Glassmaker's Funding Round

Xi'an Eswin Materials Technology (SHA:688783) will invest up to 40 million yuan in a pre-A+ funding round for Zhuhai Yiyuan Technology, according to a Friday filing with the Shanghai bourse.Zhuhai Yiyuan Technology seeks to raise between 100 million yuan and 200 million yuan in a funding round.The glass manufacturer plans to use the proceeds for capacity expansion, equipment procurement, and technology upgrades.

SHA:688783